A stepwise drug treatment algorithm to obtain complete remission in depression: a Geneva study

Area of Science:

• Psychiatry
• Pharmacology
• Clinical Medicine

Background:

• Severe depression poses significant treatment challenges.
• Optimizing antidepressant treatment algorithms is crucial for improving patient outcomes.
• Current treatment strategies for selective serotonin reuptuptake inhibitor (SSRI) non-responders require further investigation.

Purpose of the Study:

• To determine the remission rates of severely depressed outpatients at various stages of a drug treatment algorithm.
• To compare treatment options for patients who do not respond to SSRIs.
• To assess the clinical feasibility of an algorithm-guided sequential treatment protocol.

Main Methods:

• An algorithm-guided sequential treatment protocol was implemented for severely depressed outpatients (MADRS score ≥ 25).
• The protocol started with an SSRI and escalated to other treatments (e.g., tricyclic antidepressants, lithium, triiodothyronine combinations) for non-responders.
• Treatment involved boosting drug therapy based on response.

Main Results:

• Out of 131 eligible patients, 40 (30.5%) achieved complete remission.
• The median improvement in MADRS score was 48.0% among 117 patients analyzed using a last observation carried forward approach.
• 48.7% of patients were classified as responders, 23.1% as partial responders, and 28.2% as non-responders.

Conclusions:

• Algorithm-guided antidepressant treatment was found to be clinically acceptable.
• The study demonstrated an elevated final response rate among patients who completed the treatment.
• A high dropout rate (65.6%) was observed, primarily due to treatment interruption or non-adherence.